Bliss GVS Pharma informs about disclosure of related party transactions

10 Jun 2021 Evaluate

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Bliss GVS Pharma has informed that it enclosed disclosure of Related Party Transactions on the basis on consolidated financial statements for the half year ended March 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

105.40 4.10 (4.05%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.